Effect of natalizumab treatment on the rate of No Evidence of Disease Activity in young adults with multiple sclerosis in relation to pubertal stage.
J Neurol Sci
; 432: 120074, 2022 Jan 15.
Article
in En
| MEDLINE
| ID: mdl-34875473
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Multiple Sclerosis, Relapsing-Remitting
/
Multiple Sclerosis
Type of study:
Observational_studies
Limits:
Adolescent
/
Adult
/
Humans
Language:
En
Journal:
J Neurol Sci
Year:
2022
Document type:
Article